Epigenetic editing • Genetic medicines
nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.
Genomic therapies • Neurodegenerative diseases
Trace Neuroscience is a biopharmaceutical company developing genomic therapies for neurodegenerative diseases, with a focus on treating amyotrophic lateral sclerosis (ALS) by restoring the UNC13A protein.
Biopharmaceutical • Obesity
Kailera Therapeutics is a clinical-stage biopharmaceutical company developing next-generation therapies for obesity and related metabolic conditions.
Biotech • Antibody treatments
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.
AI-driven • Vehicle diagnostics
DC Connected is an AI-driven vehicle diagnostics platform that provides real-time problem-solution recommendations for multi-brand vehicles.
Biotech • Antibody treatments
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.
Biopharmaceutical • Respiratory Conditions
Aiolos Bio is a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions, with a lead drug candidate, AIO-001, that is a potentially best-in-class TSLP antibody dosed every 6 months.
Biotechnology • Oncology
Mariana Oncology is a biotechnology company that develops targeted peptide-based radiopharmaceuticals for the treatment of cancer, with a focus on delivering optimized radiation doses to solid tumors.
Computational Drug Discovery • Immunology
Nimbus Therapeutics is a clinical-stage company that uses computational chemistry and structure-based drug design to develop novel therapies for immunology, cancer, and metabolic diseases.